Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization.
GE23077 is a novel RNA polymerase inhibitor that is isolated from the fermentation broth of an Actinomadura sp. It is a cyclic heptapeptide complex made up of four factors, differing in the structure of acyl group connected to the side chain of an alpha,beta-diaminopropanoic acid moiety and in the configuration of the stereocenter of an alpha-amino-malonic acid residue. Although GE23077 shows strong inhibitory activity on both Rifampicin-sensitive and -resistant polymerases, it exhibits poor antimicrobial activity. The most reasonable explanation for this property has been based on the lack of penetration of the molecule across the bacterial membrane, owing to its strong hydrophilic character. To improve penetration, several parts of the molecule were accordingly modified with the aim of altering the physico-chemical properties of GE23077. The current SAR study has identified moieties important for RNA polymerase activity.
Vicuron Pharmaceuticals via R. Lepetit 34, 21040, Gerenzano (Varese), Italy. rmariani@gentium.it
Riccardo
R
Mariani
Giorgio
G
Granata
Sonia I
SI
Maffioli
Stefania
S
Serina
Cristina
C
Brunati
Margherita
M
Sosio
Alessandra
A
Marazzi
Alfredo
A
Vannini
Dinesh
D
Patel
Richard
R
White
Romeo
R
Ciabatti
D000192:Actinomycetales / Q000187:drug effects / Q000201:enzymology; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D015394:Molecular Structure; D010456:Peptides, Cyclic / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; C489256:GE 23077-A; C489257:GE 23077-B; D010456:Peptides, Cyclic; D012321:DNA-Directed RNA Polymerases